(833) 317-6278
Book a Demo
Blake Wilson
Gray shield icon
Is this you?
Claim your profile.

Blake Wilson

Journalist

AS SEEN ON
COGconnected, JD Supra

Preston's Summary

Blake Wilson is a journalist at various esteemed publications, including National Rugby League and WLNS-TV. He covers a diverse range of topics, with a focus on technology, healthcare, finance, and architecture, often exploring themes such as consumer tech, fintech, and the implications of cryptocurrency. Blake's work has been featured in notable outlets like The Washington Post, Editor & Publisher (E&P) Magazine, and Patch.com.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Coverage Attributes:

Beta
How To Guide: 25 %
Promotional Deal: 13 %
Government Announcement: 12 %
Industry Specific: 12 %
Review: 9 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Computer Software
  • Consumer Electronics
  • Mobile Apps
  • Phones & Tablets
  • Video Game Consoles
  • Video Games
  • Wearables
  • Web Applications
  • Crypto Exchanges
  • Crypto Regulation
  • Crypto Taxation
  • Cryptocurrency
  • Graphic Design
  • Industrial Design

Pitching Insights

Blake Wilson's coverage predominantly revolves around the gaming industry, with a particular emphasis on how-to guides and industry-specific insights. His work also touches on government announcements related to various industries.

Given his extensive focus on the gaming sector, Blake may be interested in pitches that offer unique perspectives or expert analysis related to trends in gaming, online casinos, NFTs, and specific games such as World of Warcraft. Additionally, he might appreciate contributions from professionals knowledgeable about incorporating health consciousness into business models within the entertainment or leisure sectors.

It is worth noting that although Blake does not have a specified geographic focus, his content appears to cater to an international audience due to its broad subject matter and lack of localized references.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Darrik Ferranti

Darrik Ferranti

*******ti@**************com
Publications
NerdsMagazine
Most recent topics
Not enough data
Chris Mawson

Chris Mawson

Head of SEO
**********on@************com
Publications
Power Up Gaming
Most recent topics
Not enough data
Mohit Kamboj

Mohit Kamboj

Publications
Trendingnewsbuzz
Most recent topics
Not enough data
Jonny Vito

Jonny Vito

Publications
PlayStation Universe
Most recent topics
Not enough data
Giovanni Aria

Giovanni Aria

Publications
First Comics News
Most recent topics
Not enough data
Mia Turner

Mia Turner

Publications
Morning Picker
Most recent topics
Not enough data

Articles

JD Supra

FDA warns of “important” clinical trial protocol deviations

FDA warns of “important” clinical trial protocol deviations

By: Eman Al-Hassan, Robert Church, Heidi Forster Gertner, Blake Wilson

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for sponsors, investigators, and institutional review boards (IRBs) in defining, identifying, and reporting protocol deviations in clinical trials. It spotlights concern over “important” deviations, such as incorrectly enrolled, monitored, or assessed study participants; improperly obtained, missing, or inaccurately recorded data; frequent protocol deviations for safety reporting; missing collection of protocol-specified safety laboratory values; and incorrectly performed efficacy endpoint assessment procedures. We have summarized the guidance below, for which FDA invites comments through February 28.

© 2025 Intelligent Relations